The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation.
Open accessAbstract
The 11;22 chromosomal translocation specifically linked to Ewing sarcoma and primitive neuroectodermal tumor results in a chimeric molecule fusing the amino-terminal-encoding portion of the EWS gene to the carboxyl-terminal DNA-binding domain encoded by the FLI1 gene. We have isolated a fourth EWS-FLI1 fusion cDNA that is structurally distinct from the three forms previously described. To determine the transforming activity of this gene, alternative forms of the EWS-FLI1 fusion were transduced into NIH 3T3 cells. Cells expressing either type 1 or type 4 fusion constructs formed foci in culture and colonies in soft agar, indicating that EWS-FLI1 is a transforming gene. EWS-FLI1 deletion mutants were created to map functionally the critical regions within the chimera. Deletion of either the EWS domain or the FLI1 corresponding to the DNA-binding domain totally abrogated the ability for EWS-FLI1 to transform 3T3 cells. These data indicate that the oncogenic effect of the 11;22 translocation is caused by the formation of a chimeric transcription factor. Formation of chimeric transcription factors has now been demonstrated to promote tumors of both neuroectodermal and hematopoietic origin, suggesting that this may be a common mechanism in human carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
Smith, D. B., & Johnson, K. S. (1988) · Gene · doi:10.1016/0378-1119(88)90005-4 · Cited by 5,892
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992) · Nature · doi:10.1038/359162a0 · Cited by 1,907
Self-citationMolecular themes in oncogenesis
Bishop, J. M. (1991) · Cell · doi:10.1016/0092-8674(91)90636-d · Cited by 1,637
Kakizuka, A., Miller, W. H., Umesono, K., Warrell, R. P., Frankel, S. R., Murty, V. V. V. S., Dmitrovsky, E., & Evans, R. M. (1991) · Cell · doi:10.1016/0092-8674(91)90112-c · Cited by 1,427
de Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355
de Thé, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L., & Dejean, A. (1991) · Cell · doi:10.1016/0092-8674(91)90113-d · Cited by 1,343
Kamps, M. P., Murre, C., Sun, X.-H., & Baltimore, D. (1990) · Cell · doi:10.1016/0092-8674(90)90658-2 · Cited by 697
Nourse, J., Mellentin, J. D., Galili, N., Wilkinson, J., Stanbridge, E., Smith, S. D., & Cleary, M. L. (1990) · Cell · doi:10.1016/0092-8674(90)90657-z · Cited by 662
Molecular Analysis of Acute Promyelocytic Leukemia Breakpoint Cluster Region on Chromosome 17
Borrow, J., Goddard, A. D., Sheer, D., & Solomon, E. (1990) · Science · doi:10.1126/science.2218500 · Cited by 632
Cited by
Chromosomal translocations in human cancer
Rabbitts, T. H. (1994) · Nature · doi:10.1038/372143a0 · Cited by 1,503
Whole-genome landscape of pancreatic neuroendocrine tumours
Initiative, A. P. C. G., Scarpa, A., Chang, D. K., Nones, K., Corbo, V., Patch, A.-M., Bailey, P., Lawlor, R. T., Johns, A. L., Miller, D. K., et al. (2017) · Nature · doi:10.1038/nature21063 · Cited by 999
Nanotechnology: Intelligent Design to Treat Complex Disease
Couvreur, P., & Vauthier, C. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0284-8 · Cited by 948
Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma
Galili, N., Davis, R. J., Fredericks, W. J., Mukhopadhyay, S., Rauscher, F. J., Emanuel, B. S., Rovera, G., & Barr, F. G. (1993) · Nature Genetics · doi:10.1038/ng1193-230 · Cited by 892
Grünewald, T. G. P., Cidre-Aranaz, F., Surdez, D., Tomazou, E. M., de Álava, E., Kovar, H., Sorensen, P. H., Delattre, O., & Dirksen, U. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0003-x · Cited by 873
Self-citationSorensen, P. H. B., Lessnick, S. L., Lopez-Terrada, D., Liu, X. F., Triche, T. J., & Denny, C. T. (1994) · Nature Genetics · doi:10.1038/ng0294-146 · Cited by 747
Self-citationThe Genomic Landscape of Pediatric Ewing Sarcoma
Crompton, B. D., Stewart, C., Taylor-Weiner, A., Alexe, G., Kurek, K. C., Calicchio, M. L., Kiezun, A., Carter, S. L., Shukla, S. A., Mehta, S. S., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-1037 · Cited by 566
Combinatorial generation of variable fusion proteins in the Ewing family of tumours.
Zucman, J., Melot, T., Desmaze, C., Ghysdael, J., Plougastel, B., Peter, M., Zucker, J. M., Triche, T. J., Sheer, D., & Turc-Carel, C. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06137.x · Cited by 539
Self-citationEWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.
de Alava, E., Kawai, A., Healey, J. H., Fligman, I., Meyers, P. A., Huvos, A. G., Gerald, W. L., Jhanwar, S. C., Argani, P., Antonescu, C. R., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1248 · Cited by 524
May, W. A., Lessnick, S. L., Braun, B. S., Klemsz, M., Lewis, B. C., Lunsford, L. B., Hromas, R., & Denny, C. T. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7393 · Cited by 497
Self-citationCrew, A. J., Clark, J., Fisher, C., Gill, S., Grimer, R., Chand, A., Shipley, J., Gusterson, B. A., & Cooper, C. S. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07228.x · Cited by 474
Gerald, W. L., Ladanyi, M., de Alava, E., Cuatrecasas, M., Kushner, B. H., LaQuaglia, M. P., & Rosai, J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.9.3028 · Cited by 417
Molecular Biology of the Ewing’s Sarcoma/Primitive Neuroectodermal Tumor Family
de Alava, E., & Gerald, W. L. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.204 · Cited by 360
A Proteomic Analysis of Arginine-methylated Protein Complexes
Boisvert, F.-M., Côté, J., Boulanger, M.-C., & Richard, S. (2003) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300088-mcp200 · Cited by 356
TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling
Zinszner, H., Sok, J., Immanuel, D., Yin, Y., & Ron, D. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.15.1741 · Cited by 350
Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma
Smith, R., Owen, L. A., Trem, D. J., Wong, J. S., Whangbo, J. S., Golub, T. R., & Lessnick, S. L. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.004 · Cited by 351
Self-citationHahm, K.-B., Cho, K., Lee, C., Im, Y.-H., Chang, J., Choi, S.-G., Sorensen, P. H. B., Thiele, C. J., & Kim, S.-J. (1999) · Nature Genetics · doi:10.1038/13854 · Cited by 348
Biology of EWS/ETS fusions in Ewing's family tumors
Arvand, A., & Denny, C. T. (2001) · Oncogene · doi:10.1038/sj.onc.1204598 · Cited by 348
Self-citationSpecificity within the ets Family of Transcription Factors
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60738-1 · Cited by 344
Riggi, N., Suvà, M.-L., Suvà, D., Cironi, L., Provero, P., Tercier, S., Joseph, J.-M., Stehle, J.-C., Baumer, K., Kindler, V., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1761 · Cited by 332
Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance
Schram, A. M., Chang, M. T., Jonsson, P., & Drilon, A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.127 · Cited by 323
Grier, H. E. (1997) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70541-1 · Cited by 321
Microsatellites as EWS/FLI response elements in Ewing's sarcoma
Gangwal, K., Sankar, S., Hollenhorst, P. C., Kinsey, M., Haroldsen, S. C., Shah, A. A., Boucher, K. M., Watkins, W. S., Jorde, L. B., Graves, B. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801073105 · Cited by 297
Self-citationGerald, W. L., Rosai, J., & Ladanyi, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1028 · Cited by 301
Bailly, R.-A., Bosselut, R., Zucman, J., Cormier, F., Delattre, O., Roussel, M., Thomas, G., & Ghysdael, J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.5.3230-3241.1994 · Cited by 297
Self-citationRiggi, N., & Stamenkovic, I. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.009 · Cited by 282
Tanaka, K., Iwakuma, T., Harimaya, K., Sato, H., & Iwamoto, Y. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119152 · Cited by 277
Lessnick, S. L., Dacwag, C. S., & Golub, T. R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00056-9 · Cited by 264
Self-citationZinszner, H., Albalat, R., & Ron, D. (1994) · Genes & Development · doi:10.1101/gad.8.21.2513 · Cited by 264
Bertolotti, A., Melot, T., Acker, J., Vigneron, M., Delattre, O., & Tora, L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1489 · Cited by 261
Self-citationPromiscuous partnerships in Ewing's sarcoma
Sankar, S., & Lessnick, S. L. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2011.07.008 · Cited by 258
Self-citationSchaser, A. J., Osterberg, V. R., Dent, S. E., Stackhouse, T. L., Wakeham, C. M., Boutros, S. W., Weston, L. J., Owen, N., Weissman, T. A., Luna, E., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47227-z · Cited by 256
Jousset, C., Carron, C., Boureux, A., Quang, C. T., Oury, C., Dusanter‐Fourt, I., Charon, M., Levin, J., Bernard, O., & Ghysdael, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.1.69 · Cited by 207
EWS–ETS oncoproteins: The linchpins of Ewing tumors
Janknecht, R. (2005) · Gene · doi:10.1016/j.gene.2005.08.007 · Cited by 173
The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities.
Mao, X., Miesfeldt, S., Yang, H., Leiden, J. M., & Thompson, C. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32437-7 · Cited by 132
Solution structure of the ets domain of Fli-1 when bound to DNA
Liang, H., Mao, X., Olejniczak, E. T., Nettesheim, D. G., Yu, L., Meadows, R. P., Thompson, C. B., & Fesik, S. W. (1994) · Nature Structural & Molecular Biology · doi:10.1038/nsb1294-871 · Cited by 104
Luo, W., Gangwal, K., Sankar, S., Boucher, K. M., Thomas, D., & Lessnick, S. L. (2009) · Oncogene · doi:10.1038/onc.2009.262 · Cited by 93
“EWS/FLI requires both its strong transcriptional activation domain (derived from EWS) and its ETS-type DNA-binding domain (derived from FLI) for oncogenic function (May et al., 1993a, b).”
BackgroundSelf-citationDNA Binding by the ETS Protein TEL (ETV6) Is Regulated by Autoinhibition and Self-association
Green, S. M., Coyne, H. J., McIntosh, L. P., & Graves, B. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.096958 · Cited by 69
Bojović, B. B., & Hassell, J. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005509200 · Cited by 68
Emergent Properties of EWS/FLI Regulation via GGAA Microsatellites in Ewing's Sarcoma
Gangwal, K., Close, D., Enriquez, C. A., Hill, C. P., & Lessnick, S. L. (2010) · Genes & Cancer · doi:10.1177/1947601910361495 · Cited by 67
“2A).(14) We found that Δ22 was inactive in luciferase reporter assays (Fig.”
Self-citationCurrent insights into the role of Fli-1 in hematopoiesis and malignant transformation
Ben-David, Y., Gajendran, B., Sample, K. M., & Zacksenhaus, E. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04160-1 · Cited by 54
Metadata
- Authors
- May, W. A., Gishizky, M. L., Lessnick, S. L., Lunsford, L. B., Lewis, B. C., Delattre, O., Zucman, J., Thomas, G., & Denny, C. T.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1993-06-15
- Volume
- 90
- Issue
- 12
- Pages
- 5752-5756
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2025989401
- Cited by
- 574
- References
- 31
- FWCI
- 19.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.